中文
About Us
Company Profile
Our Mission
Prof. Chang, Lung-JI
News
NCI Project
Blood Cancer
Solid Tumor
Gene Therapy
Autoimmune Diseases
Service
Immune technology portfolio
CAR-T technology
EIE technology
Cancer vaccines
Case Study
Blood Cancer Research
Solid Tumor Research
Integrated Case Studies
Contact Us
Home
About Us
Company Profile
Our Mission
Prof. Chang, Lung-JI
News
NCI Project
Blood Cancer
Solid Tumor
Gene Therapy
Autoimmune Diseases
Service
Immune technology portfolio
CAR-T technology
EIE technology
Cancer vaccines
Case Study
血液肿瘤
实体肿瘤
基因治疗
自身免疫疾病
Contact Us
Case Study
Blood Cancer Research
Solid Tumor Research
Integrated Case Studies
Home
/
Case Study
/ Blood Cancer Research
Partial remission for 3 years after MAGE-A4-specific T cell immunotherapy targeting metastatic lung adenocarcinoma
More ⇢
Case2# The CR patient of Diffuse Intrinsic Pontine Glioma
More ⇢
Case3# The CR patient of Primary Mediastinal B-large Cell Lymphoma with spread to the CNS
More ⇢
Case4# The PR patient of severe Hodgkin lymphoma
More ⇢
Case6# The CR patient of Primary Mediastinal B-large Cell Lymphoma with spread to the lymph nodes
More ⇢
Case7# A 5-year long term CR patient of late-stage refractory diffuse large B cell lymphoma
More ⇢
Case8#The CR patient of high burden refractory Burkitt lymphoma
More ⇢
Case9# The PR patient of mucosa-associated lymphoid tissue lymphoma for many years
More ⇢
Case10# The First Japanese CART Experience with 4SCART Therapy
More ⇢
case12# The first South America B-Acute Lymphoblastic Leukemia (B-ALL) boy came to China for CART therapy…
More ⇢
TEL：010-82346080
Wechat
